Geron 8-K 2012
Date of Report (Date of earliest event reported): March 13, 2012
230 CONSTITUTION DRIVE
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Election of Director
On March 13, 2012, the Board of Directors (the Board) of Geron Corporation (the Company) appointed V. Bryan Lawlis, Ph.D., to the Board, effective immediately. Dr. Lawlis fills a vacant Class III Board position, expiring at the Companys 2014 Annual Meeting of Stockholders. Dr. Lawlis was also appointed to the Compensation Committee of the Board, effective on March 13, 2012.
There is no arrangement or understanding between Dr. Lawlis and the Company, pursuant to which he was selected as a director.
In connection with Dr. Lawlis appointment, the Company granted to Dr. Lawlis a nonstatutory stock option to purchase 70,000 shares of the Companys Common Stock (the First Option) as provided by the Companys 2006 Directors Stock Option Plan (the Directors Plan), as amended on March 13, 2012, at an exercise price equal to $1.73 per share, the closing sale price of the Companys Common Stock as reported on the Nasdaq Global Select Market on March 13, 2012 (the Grant Date). The First Option shall have a maximum term of ten (10) years measured from the Grant Date, and shall be exercisable in a series of three (3) equal consecutive annual installments on the anniversary of the Grant Date, commencing on the Grant Date, provided Dr. Lawlis continues to provide services to the Company. Dr. Lawlis will also receive cash compensation for his services as a non-employee director as described under Compensation of Directors in the Companys definitive proxy statement for its next Annual Meeting of Stockholders.
Compensatory Arrangements of Certain Officers
On March 13, 2012, the Compensation Committee of the Board approved annual base salaries for 2012 for the following named executive officers of the Company:
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.